EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications

Yanjin Qin, Jing Zhang iD, Danyang Xu, Xiaoqi Zhou, Zhoukun Ling, Lujie Li, Qiaochu Zhao, Zhi Dong, Jifei Wang, Hua-Song Cai, Hongxiang Li, Lie-Guang Zhang und 1 weitere

Liver International · 2025

DOI: 10.1111/liv.70366 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Yanjin Qin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Gadolinium DTPA, Liver Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Municipality Science and Technology Bureau of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The diagnostic performance of the Liver Imaging Reporting and Data System (LI‐RADS) version 2018 (v2018), its modifications modified LI‐RADS (mLI‐RADS) and revised LI‐RADS (rLI‐RADS), for diagnosing hepatocellular carcinoma (HCC) remains poorly understood and requires further validation. This multicentre study aimed to evaluate the diagnostic performance of three algorithms in diagnosing HCC.

Methods

We included 1092 untreated patients at risk for developing HCC who underwent gadoxetic acid–enhanced MRI across three independent cohorts from January 2020 to December 2022. Two readers independently interpreted each hepatic lesion and recorded their imaging features. The readers' judgements regarding whether the lesion was HCC or not were also noted. Non‐HCC cases were confirmed based on histologic and clinical follow‐up data, while HCC cases were pathologically confirmed. Diagnostic performance metrics were compared using bootstrap resampling and generalised estimating equations. Additionally, the diagnostic odds ratio (DOR) was evaluated.

Results

Of 1313 lesions, 52.3% (687/1313) were diagnosed as HCC. For all hepatic lesions, mLI‐RADS achieved higher sensitivity (82.9%) and accuracy (84.1%) than LI‐RADS v2018 (sensitivity, 79.9%, p = 0.024; accuracy, 83.2%) and rLI‐RADS (sensitivity, 81.3%; accuracy, 83.8%), while maintaining a similar positive predictive value (mLI‐RADS, 86.2%; LI‐RADS v2018, 86.9%; rLI‐RADS, 86.9%). The DORs were 28.3 (95% CI: 21.1–38.0) for mLI‐RADS, 27.8 (95% CI: 20.6–37.7) for LI‐RADS v2018 and 26.0 (95% CI: 19.3–35.0) for rLI‐RADS. The readers' judgement exhibited higher accuracy than that of three algorithms (87.7%: 83.2%–84.1%).

Conclusion

For the diagnosis of HCC in an HBV‐predominant cohort, mLI‐RADS showed higher performance compared with LI‐RADS v2018 and rLI‐RADS. Reader judgement achieved higher accuracy than all algorithms, highlighting the role of clinical expertise. Trial Registration NCT06663904

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularGadolinium DTPALiver NeoplasmsMagnetic Resonance ImagingAdultAgedFemaleHumansMaleMiddle AgedAlgorithmsContrast MediaLiverRetrospective Studies

Stichwörter der Autor:innen

Liver Imaging Reporting and Data Systemdiagnosishepatocellular carcinomamagnetic resonance imagingsubgroups analysis

Substanzen

Contrast MediaGadolinium DTPAgadolinium ethoxybenzyl DTPA

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Radiology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Jing Zhang, Shi-Ting Feng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Municipality Science and Technology Bureau of Guangzhou

Zitieren

APA

Qin, Y., Zhang, J., Xu, D., Zhou, X., Ling, Z., Li, L., Zhao, Q., Dong, Z., Wang, J., Cai, H. S., Li, H., Zhang, L. G., & Feng, S. T. (2025). Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications. Liver International. https://doi.org/10.1111/liv.70366

Vancouver

Qin Y, Zhang J, Xu D, Zhou X, Ling Z, Li L, et al. Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications. Liver International. 2025. doi:10.1111/liv.70366

BibTeX
@article{Qin2025,
  author = {Qin, Yanjin and Zhang, Jing and Xu, Danyang and Zhou, Xiaoqi and Ling, Zhoukun and Li, Lujie and Zhao, Qiaochu and Dong, Zhi and Wang, Jifei and Cai, Hua-Song and Li, Hongxiang and Zhang, Lie-Guang and Feng, Shi-Ting},
  title = {Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI ‐ RADS Version 2018 and LI ‐ RADS Modifications},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70366}
}
Kostenlos starten →